CHAPTER 1. Industry Overview of Pain Management Market
1.1. Definition and Scope
1.1.1. Definition of Pain Management
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pain Management Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pain Management Market By Mode Of Pain Management
1.2.3. Pain Management Market By Application
1.2.4. Pain Management Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pain Management Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pain Management Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Pain Management Market By Mode Of Pain Management
4.1. Introduction
4.2. Pain Management Revenue By Mode Of Pain Management
4.2.1. Pain Management Revenue (USD Million) and Forecast, By Mode Of Pain Management, 2018-2030
4.2.2. Drugs
4.2.2.1. Drugs Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2. Opioids
4.2.2.2.1. Opioids Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3. Non-Narcotic Analgesics
4.2.2.3.1. Non-Narcotic Analgesics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.2. NSAIDS
4.2.2.3.2.1. NSAIDS Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.3. Anesthetics
4.2.2.3.3.1. Anesthetics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.4. Anticonvulsants
4.2.2.3.4.1. Anticonvulsants Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.5. Anti-Depressants
4.2.2.3.5.1. Anti-Depressants Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.6. Other Non-Narcotic Analgesics
4.2.2.3.6.1. Other Non-Narcotic Analgesics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Devices
4.2.3.1. Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.2. Neurostimulation Devices
4.2.3.2.1. Neurostimulation Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.2.2. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
4.2.3.2.2.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.2.3. Brain and Spinal Cord Stimulation (SCS) Devices
4.2.3.2.3.1. Brain and Spinal Cord Stimulation (SCS) Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.3. Analgesics Infusion Pumps
4.2.3.3.1. Analgesics Infusion Pumps Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.3.2. Intrathecal Infusion Pumps
4.2.3.3.2.1. Intrathecal Infusion Pumps Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.3.3. External Infusion Pumps
4.2.3.3.3.1. External Infusion Pumps Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Pain Management Market By Application
5.1. Introduction
5.2. Pain Management Revenue By Application
5.2.1. Pain Management Revenue (USD Million) and Forecast, By Application, 2018-2030
5.2.2. Neuropathic Pain
5.2.2.1. Neuropathic Pain Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Cancer Pain
5.2.3.1. Cancer Pain Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Facial Pain and Migraine
5.2.4.1. Facial Pain and Migraine Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Musculoskeletal Pain
5.2.5.1. Musculoskeletal Pain Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.6. Other Applications
5.2.6.1. Other Applications Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Pain Management Market By Country
6.1. North America Pain Management Market Overview
6.2. U.S.
6.2.1. U.S. Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
6.2.2. U.S. Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
6.3. Canada
6.3.1. Canada Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
6.3.2. Canada Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Pain Management Market By Country
7.1. Europe Pain Management Market Overview
7.2. U.K.
7.2.1. U.K. Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.2.2. U.K. Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.3. Germany
7.3.1. Germany Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.3.2. Germany Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.4. France
7.4.1. France Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.4.2. France Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.5. Spain
7.5.1. Spain Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.5.2. Spain Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.6. Rest of Europe
7.6.1. Rest of Europe Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.6.2. Rest of Europe Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Pain Management Market By Country
8.1. Asia Pacific Pain Management Market Overview
8.2. China
8.2.1. China Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.2.2. China Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.3. Japan
8.3.1. Japan Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.3.2. Japan Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.4. India
8.4.1. India Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.4.2. India Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.5. Australia
8.5.1. Australia Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.5.2. Australia Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.6. South Korea
8.6.1. South Korea Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.6.2. South Korea Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.7.2. Rest of Asia-Pacific Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Pain Management Market By Country
9.1. Latin America Pain Management Market Overview
9.2. Brazil
9.2.1. Brazil Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
9.2.2. Brazil Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
9.3. Mexico
9.3.1. Mexico Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
9.3.2. Mexico Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
9.4.2. Rest of Latin America Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Pain Management Market By Country
10.1. Middle East & Africa Pain Management Market Overview
10.2. GCC
10.2.1. GCC Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
10.2.2. GCC Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
10.3. South Africa
10.3.1. South Africa Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
10.3.2. South Africa Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
10.4.2. Rest of Middle East & Africa Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Pain Management Market
11.1. Pain Management Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Pain Management Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Million), 2021
12.1.3.2. Abbott Laboratories 2021 Pain Management Business Regional Distribution
12.1.4. Product /Service and Specification
12.1.5. Recent Developments & Business Strategy
12.2. AstraZeneca PLC
12.3. Baxter International Inc.
12.4. Becton, Dickinson and Company
12.5. Boston Scientific Corporation
12.6. Fresenius SE & Co. KGaA
12.7. GlaxoSmithKline PLC
12.8. Johnson & Johnson
12.9. Medtronic PLC
12.10. Novartis International AG
12.11. Pfizer Inc
The market size of pain management market in 2021 was accounted to be USD 48,518 Million.
The projected CAGR of pain management market during the analysis period of 2022 to 2030 is 6.5%.
The prominent players of the global pain management market are Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Fresenius SE & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson, Medtronic PLC, Novartis International AG, and Pfizer Inc.
North America held the dominating pain management during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for pain management during the analysis period of 2022 to 2030.
Growing incidences of chronic pain, rising prevalence of sport injuries, and increasing number of surgical procedures drives the growth of global pain management market.
Based on mode of pain management, drugs segment is expected to hold the maximum share pain management market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date